ArticleBMJ case reports2021

Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.

Joana Vasconcelos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.